Inventor · disambiguated record
Takahiro Morikawa
Also filed as: MORIKAWA TAKAHIRO
1 granted patent·4 pending applications·0 citations·filing 2022–2025
12Inventor score
Files withASTELLAS PHARMA INC5
Top patents by PatentIndex Score
5 records- 0167US2025340561A1Quinazoline compound for inducing degradation of g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2025·Application pending·0 cites
- 0264US12384794B2Quinazoline compound for inducing degradation of G12D mutant KRAS proteinASTELLAS PHARMA INC·Filed 2022·Granted Aug 12, 2025·0 cites·37 claims
- 0363US2025145631A1Heterocyclic compound acting on g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0460US2025206751A1Heterocyclic compound for inducing degradation of g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0555US2024150366A14-aminoquinazoline compoundASTELLAS PHARMA INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takahiro Morikawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →